We are live on ! Find out more
CA

Capital Advantage Portfolio holdings

AUM $834M Turnover 14.46%
1-Year Est. Return 15.6%
This Fund
S&P 500
This Quarter Est. Return
-1.77%
1 Year Est. Return
+15.6%
3 Year Est. Return
+49.19%
5 Year Est. Return
+46.21%
10 Year Est. Return
–
AUM
$192M
AUM Growth
+$10.6M
Cap. Flow
+$14.2M
Cap. Flow %
7.4%
Top 10 Hldgs %
79.37%
Holding
57
New
1
Increased
26
Reduced
11
Closed
1
Avg Time Held
0.6 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.6 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
T icon
26
AT&T
T
$162B
$784K 0.41%
29,448
+186
+0.6% +$4.95K
2013 Q4
3 quarters
PG icon
27
Procter & Gamble
PG
$369B
$720K 0.38%
8,598
+662
+8% +$54.2K
2013 Q4
3 quarters
IVV icon
28
iShares Core S&P 500 ETF
IVV
$889B
$666K 0.35%
3,361
-30
-0.9% -$5.97K
2013 Q4
3 quarters
MCK icon
29
McKesson
MCK
$116B
$594K 0.31%
3,050
– –
2013 Q4
3 quarters
CSCO icon
30
Cisco
CSCO
$430B
$544K 0.28%
21,607
+27
+0.1% +$679
2013 Q4
3 quarters
PEP icon
31
PepsiCo
PEP
$178B
$416K 0.22%
4,465
+6
+0.1% +$548
2013 Q4
3 quarters
PFE icon
32
Pfizer
PFE
$169B
$408K 0.21%
14,528
-134
-0.9% -$3.76K
2013 Q4
3 quarters
SHY icon
33
iShares 1-3 Year Treasury Bond ETF
SHY
$26.8B
$403K 0.21%
4,773
-5,464
-53% -$462K
2013 Q4
3 quarters
AMZN icon
34
Amazon
AMZN
$2.74T
$401K 0.21%
24,880
+5,920
+31% +$98.5K
2013 Q4
3 quarters
MCD icon
35
McDonald's
MCD
$172B
$355K 0.19%
3,744
– –
2013 Q4
3 quarters
MRK icon
36
Merck
MRK
$372B
$345K 0.18%
6,098
+4
+0.1% +$225
2013 Q4
3 quarters
VZ icon
37
Verizon
VZ
$187B
$321K 0.17%
6,424
+2
+0% +$99
2013 Q4
3 quarters
TWTR
38
DELISTED
Twitter, Inc.
TWTR
$306K 0.16%
5,941
– –
2014 Q2
1 quarter
QCOM icon
39
Qualcomm
QCOM
$188B
$291K 0.15%
3,895
+1
+0% +$76
2013 Q4
3 quarters
AMGN icon
40
Amgen
AMGN
$238B
$288K 0.15%
2,054
+1
+0% +$131
2013 Q4
3 quarters
TEVA icon
41
Teva Pharmaceutical Industries Limited
TEVA
$48.4B
$288K 0.15%
5,351
– –
2013 Q4
3 quarters
IBM icon
42
IBM
IBM
$218B
$268K 0.14%
1,478
– –
2013 Q4
3 quarters
UNP icon
43
Union Pacific
UNP
$171B
$255K 0.13%
2,352
– –
2014 Q1
2 quarters
KO icon
44
Coca-Cola
KO
$400B
$253K 0.13%
5,920
– –
2014 Q2
1 quarter
AXP icon
45
American Express
AXP
$209B
$239K 0.12%
2,729
-200
-7% -$18K
2014 Q2
1 quarter
VFH icon
46
Vanguard Financials ETF
VFH
$13B
$232K 0.12%
4,992
– –
2013 Q4
3 quarters
DIS icon
47
Walt Disney
DIS
$192B
$231K 0.12%
2,596
– –
2014 Q1
2 quarters
BA icon
48
Boeing
BA
$148B
$225K 0.12%
1,765
– –
2014 Q1
2 quarters
MMM icon
49
3M
MMM
$86B
$223K 0.12%
1,883
– –
2013 Q4
3 quarters
WBA icon
50
DELISTED
Walgreens Boots Alliance
WBA
$219K 0.11%
3,698
– –
2013 Q4
3 quarters

Similar funds

Capital Advantage's Q3 2014 Portfolio in Review

As of Q3 2014, Capital Advantage held 57 positions worth $192M, up 5.9% from $181M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Capital Advantage deployed $14.2M of net new capital in Q3 2014, opening 1 new position and adding to 26 existing holdings. Its largest new stake was Bristol-Myers Squibb: 3,965 shares worth $203K.

By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, up from 87% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $1.06M trimmed.

  • Capital Advantage's largest Q3 2014 buy was Bristol-Myers Squibb: 3,965 shares worth $203K.
  • Capital Advantage added most to Invesco BulletShares 2018 Corporate Bond ETF in Q3 2014, an estimated $3.12M increase.
  • Capital Advantage's biggest Q3 2014 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.06M.
  • Capital Advantage fully exited iShares MSCI Emerging Markets Min Vol Factor ETF in Q3 2014, selling an estimated $211K.
  • Capital Advantage's ten largest holdings make up 79% of its $192M portfolio in Q3 2014.
  • Capital Advantage opened 1 new position and closed 1 in Q3 2014.
  • Capital Advantage's portfolio value rose 5.9% quarter-over-quarter to $192M.

Based on Capital Advantage's 13F filing for Q3 2014, filed 22 Jun 2016.